Related references
Note: Only part of the references are listed.Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
T. Byrski et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
High Incidence of Protein-Truncating TP53 Mutations in BRCA1-Related Breast Cancer
Henne Holstege et al.
CANCER RESEARCH (2009)
High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors
Elodie Manie et al.
CANCER RESEARCH (2009)
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.
Peter C. Fong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors
Norazizah Shafee et al.
CANCER RESEARCH (2008)
Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance
Elizabeth M. Swisher et al.
CANCER RESEARCH (2008)
BRCAness Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated With BRCA1 and BRCA2 Mutations
David S. P. Tan et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The basal-like mammary carcinomas induced by Brca1 or Bard1 inactivation implicate the BRCA1/BARD1 heterodimer in tumor suppression
Reena Shakya et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
E3 ligase activity of BRCA1 is not essential for mammalian cell viability or homology-directed repair of double-strand DNA breaks
Latarsha J. Reid et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
BRCA1 regulates human mammary stem/progenitor cell fate
Suling Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs
Sven Rottenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers
T. Byrski et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair
Lao H. Saal et al.
NATURE GENETICS (2008)
Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer
Xiaoling Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer
Sven Rottenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A mouse model of basal-like breast carcinoma with metaplastic elements
A. McCarthy et al.
JOURNAL OF PATHOLOGY (2007)
Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist
Aleksandra Jovanovic Poole et al.
SCIENCE (2006)
Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects
B. Evers et al.
ONCOGENE (2006)
The role of BRCA1 in transcriptional regulation and cell cycle control
P. B. Mullan et al.
ONCOGENE (2006)
Hyperplasia and spontaneous tumor development in the gynecologic system in mice lacking the BRCA1-Δ11 isoform
Sang Soo Kim et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance
G Chenevix-Trench et al.
CANCER RESEARCH (2006)
BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution
CX Deng
NUCLEIC ACIDS RESEARCH (2006)
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
HE Bryant et al.
NATURE (2005)
Prevention and management of hereditary breast cancer
SA Narod et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Identification of BRCA1-IRIS, a BRCA1 locus product
WM ElShamy et al.
NATURE CELL BIOLOGY (2004)
Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer
WD Foulkes et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
BRCA1 supports XIST RNA concentration on the inactive X chromosome
S Ganesan et al.
CELL (2002)
Conditional mouse models of sporadic cancer
J Jonkers et al.
NATURE REVIEWS CANCER (2002)
Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice
SG Brodie et al.
ONCOGENE (2001)
Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis
XL Xu et al.
NATURE GENETICS (2001)
Impaired DNA damage response in cells expressing an exon 11-deleted murine Brca1 variant that localizes to nuclear foci
LJ Huber et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Tumorigenesis in mice carrying a truncating Brca1 mutation
T Ludwig et al.
GENES & DEVELOPMENT (2001)
The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation
R Hashizume et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
A targeted mouse Brca1 mutation removing the last BRCT repeat results in apoptosis and embryonic lethality at the headfold stage
P Hohenstein et al.
ONCOGENE (2001)
Apparent human BRCAI knockout caused by mispriming during polymerase chain reaction:: Implications for genetic testing
B Kuschel et al.
GENES CHROMOSOMES & CANCER (2001)
BracI required for T cell linage development but not TCR loci rearrangement
TW Mak et al.
NATURE IMMUNOLOGY (2000)
Share Paper
